iShares Health Innovation Active ETF (BMED)
NYSEARCA: BMED · Real-Time Price · USD
34.42
+0.14 (0.41%)
At close: Sep 3, 2026, 4:00 PM EDT
35.01
+0.59 (1.71%)
After-hours: Sep 3, 2026, 4:18 PM EDT
BMED Holdings Information
BMED is an equity ETF with a total of 62 individual holdings. The top holdings are Merck & Co. stock at 5.89%, Gilead Sciences at 4.94%, Edwards Lifesciences at 4.55%, Johnson & Johnson at 4.40%, and Charles River Laboratories International at 4.31%.
Total Holdings
62
Top 10 Percentage
43.23%
Asset Class
Equity
ETF Category
Health
Assets
13.56M
PE Ratio
30.89
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRK | Merck & Co., Inc. | 5.89% |
| 2 | GILD | Gilead Sciences, Inc. | 4.94% |
| 3 | EW | Edwards Lifesciences Corporation | 4.55% |
| 4 | JNJ | Johnson & Johnson | 4.40% |
| 5 | CRL | Charles River Laboratories International, Inc. | 4.31% |
| 6 | XTSLA | BLK CSH FND TREASURY SL AGENCY | 4.17% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 4.15% |
| 8 | WAT | Waters Corporation | 3.68% |
| 9 | DHR | Danaher Corporation | 3.64% |
| 10 | BIIB | Biogen Inc. | 3.50% |
| 11 | MTD | Mettler-Toledo International Inc. | 3.36% |
| 12 | ABBV | AbbVie Inc. | 3.29% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 3.06% |
| 14 | DXCM | DexCom, Inc. | 2.74% |
| 15 | MRNA | Moderna, Inc. | 2.67% |
| 16 | AMGN | Amgen Inc. | 2.59% |
| 17 | TECH | Bio-Techne Corporation | 2.36% |
| 18 | ILMN | Illumina, Inc. | 2.16% |
| 19 | SWX: ROP | Roche Holding AG | 2.07% |
| 20 | SWX: NOVN | Novartis AG | 2.07% |
| 21 | INCY | Incyte Corporation | 2.05% |
| 22 | IQV | IQVIA Holdings Inc. | 1.93% |
| 23 | ARGX | argenx SE | 1.83% |
| 24 | ABT | Abbott Laboratories | 1.72% |
| 25 | CYTK | Cytokinetics, Incorporated | 1.64% |
As of Aug 13, 2026